JP2001513629A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513629A5 JP2001513629A5 JP1998536415A JP53641598A JP2001513629A5 JP 2001513629 A5 JP2001513629 A5 JP 2001513629A5 JP 1998536415 A JP1998536415 A JP 1998536415A JP 53641598 A JP53641598 A JP 53641598A JP 2001513629 A5 JP2001513629 A5 JP 2001513629A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9703592.7A GB9703592D0 (en) | 1997-02-21 | 1997-02-21 | Poxvirus chemokine-binding protein |
| GB9703592.7 | 1997-02-21 | ||
| GBGB9800113.4A GB9800113D0 (en) | 1998-01-05 | 1998-01-05 | A soluble vaccinia virus protein that binds chemokines |
| GB9800113.4 | 1998-01-05 | ||
| PCT/GB1998/000569 WO1998037217A1 (en) | 1997-02-21 | 1998-02-23 | A soluble vaccinia virus protein that binds chemokines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001513629A JP2001513629A (ja) | 2001-09-04 |
| JP2001513629A5 true JP2001513629A5 (https=) | 2004-12-09 |
| JP4191255B2 JP4191255B2 (ja) | 2008-12-03 |
Family
ID=26311039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53641598A Expired - Fee Related JP4191255B2 (ja) | 1997-02-21 | 1998-02-23 | ケモカイン類に結合する可溶性ワクシニアウイルスタンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6355252B1 (https=) |
| EP (2) | EP0985046B1 (https=) |
| JP (1) | JP4191255B2 (https=) |
| AT (1) | ATE323170T1 (https=) |
| AU (1) | AU749921B2 (https=) |
| DE (1) | DE69834179T2 (https=) |
| WO (1) | WO1998037217A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE323170T1 (de) * | 1997-02-21 | 2006-04-15 | Oxxon Therapeutics Ltd | Rekombinantes pockenvirus das das lösliche chemokine-bindende protein kodierende gen a41l nicht exprimieren kann. |
| GB9711957D0 (en) * | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| US20040241163A1 (en) * | 2001-04-05 | 2004-12-02 | Thomas Shenk | Compositions and methods for treating inflammation and related conditions |
| WO2003005953A2 (en) * | 2001-07-12 | 2003-01-23 | Immunex Corporation | Viral proteins capable of binding lar |
| GB0118532D0 (en) * | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| CA2460321A1 (en) * | 2001-09-20 | 2003-03-27 | Schering Corporation | Chemokines as adjuvants of immune response |
| AU2003259117A1 (en) * | 2002-07-10 | 2004-01-23 | The Regents Of The University Of California | Antimicrobial activity of interferon-inducible elr chemokines |
| KR20120002613A (ko) | 2002-08-12 | 2012-01-06 | 제네렉스, 인코포레이티드 | 폭스바이러스 및 암과 관련된 방법 및 조성물 |
| US20100189747A1 (en) * | 2003-07-31 | 2010-07-29 | Raymond Weinstein | Compositions and methods for treating or preventing hiv infection |
| US20050175627A1 (en) * | 2003-09-24 | 2005-08-11 | Oxxon Therapeutics Ltd. | HIV pharmaccines |
| WO2006076383A2 (en) * | 2005-01-11 | 2006-07-20 | Rosetta Stone Labs, Llc | Composition and method for inducing a protective vaccine response |
| US20070160571A1 (en) * | 2006-01-11 | 2007-07-12 | Mitchell Krathwohl | Composition and method for inducing protective vaccine response |
| KR101772375B1 (ko) * | 2005-09-07 | 2017-08-29 | 신라젠(주) | Ｇｍ-ｃｓｆ를 발현하는 폭스바이러스를 사용한 전이성 및/또는 전신 파종성 암의 전신 치료법 |
| US8980246B2 (en) | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
| WO2007041317A2 (en) * | 2005-09-29 | 2007-04-12 | Viral Logic Systems Technology Corp. | Immunomodulatory compositions and uses therefor |
| DK2005185T3 (da) | 2006-03-22 | 2011-01-31 | Viral Logic Systems Technology Corp | Fremgangsmåde til identifikation af polypeptidtargets |
| WO2008096359A2 (en) * | 2007-02-08 | 2008-08-14 | Rappaport Family Institute For Research In The Medical Sciences | Agents for the treatment of multiple sclerosis and methods of using same |
| KR20080084528A (ko) * | 2007-03-15 | 2008-09-19 | 제네렉스 바이오테라퓨틱스 인크. | 종양살상형 백시니아 바이러스 암 치료 |
| US8263064B2 (en) | 2007-06-04 | 2012-09-11 | Rappaport Family Institute For Research In The Medical Sciences | Method of suppressing disease severity of multiple sclerosis using chemokine CXC11 |
| WO2009082594A2 (en) * | 2007-11-26 | 2009-07-02 | Fox Chase Cancer Center | Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents |
| WO2010103517A1 (en) | 2009-03-12 | 2010-09-16 | Rappaport Family Institute For Research In The Medical Sciences | Soluble compositions for the treatment of cxcr3-ligand associated diseases |
| ES2848650T3 (es) | 2009-09-14 | 2021-08-11 | Sillajen Biotherapeutics Inc | Terapia combinada contra el cáncer con virus vaccinia oncolítico |
| AU2012204467B2 (en) | 2011-01-04 | 2016-08-18 | Sillajen, Inc. | Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69628838T2 (de) * | 1995-04-19 | 2004-05-06 | The John P. Robarts Research Institute, London | Chemokin bindendes protein und verfahren zu seiner verwendung |
| US6140064A (en) | 1996-09-10 | 2000-10-31 | Theodor-Kocher Institute | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| ATE323170T1 (de) * | 1997-02-21 | 2006-04-15 | Oxxon Therapeutics Ltd | Rekombinantes pockenvirus das das lösliche chemokine-bindende protein kodierende gen a41l nicht exprimieren kann. |
| WO1998036766A1 (en) * | 1997-02-21 | 1998-08-27 | Isis Innovation Limited | Anti-hiv protein |
| JP2001168323A (ja) * | 1999-12-06 | 2001-06-22 | Mitsubishi Electric Corp | 半導体装置の製造方法 |
-
1998
- 1998-02-23 AT AT98907032T patent/ATE323170T1/de not_active IP Right Cessation
- 1998-02-23 EP EP98907032A patent/EP0985046B1/en not_active Expired - Lifetime
- 1998-02-23 US US09/367,781 patent/US6355252B1/en not_active Expired - Fee Related
- 1998-02-23 WO PCT/GB1998/000569 patent/WO1998037217A1/en not_active Ceased
- 1998-02-23 AU AU63020/98A patent/AU749921B2/en not_active Ceased
- 1998-02-23 EP EP20030022117 patent/EP1405916A1/en not_active Withdrawn
- 1998-02-23 DE DE69834179T patent/DE69834179T2/de not_active Expired - Fee Related
- 1998-02-23 JP JP53641598A patent/JP4191255B2/ja not_active Expired - Fee Related
-
2002
- 2002-01-15 US US10/047,761 patent/US20020071849A1/en not_active Abandoned
-
2004
- 2004-02-18 US US10/781,262 patent/US7384643B2/en not_active Expired - Fee Related